Cormorant Asset Management, LP
Annual return '25
+38.8%
SPY '25
+17.7%
Alpha
+21.1ptsvs SPY
Invested
$4B
Holdings
46
Trades YTD
5
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 99%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$PRAX
PRAXIS PRECISION MEDICINES I
Held since at least Q1 2024
14.8%
02
$BBOT
BRIDGEBIO ONCOLOGY THERAPEUT
Held since at least Q1 2024
8.3%
03
$EYPT
EYEPOINT INC
Held since at least Q1 2024
5.5%
04
$EWTX
EDGEWISE THERAPEUTICS INC
Held since at least Q1 2024
5.3%
05
$ERAS
ERASCA INC
Held since at least Q1 2024
4.9%
06
$RAPP
RAPPORT THERAPEUTICS INC
Held since at least Q1 2024
4.8%
07
$ALMS
ALUMIS INC
Held since at least Q1 2024
4.5%
08
$ABVX
ABIVAX SA
Held since at least Q1 2024
4.4%
09
$MLTX
MOONLAKE IMMUNOTHERAPEUTICS
Held since at least Q1 2024
4.3%
10
$DNTH
DIANTHUS THERAPEUTICS INC
Held since at least Q1 2024
4.1%
Recent trades · Last 90 days
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:42 UTC.